10 results
10-Q
2022 Q1
HLVX
HilleVax Inc
8 Jun 22
Quarterly report
4:25pm
recipients;
sales of the vaccine may decrease significantly or the vaccine could become less competitive; and
our reputation may suffer.
Any … resources. Regardless of the merits or eventual outcome, liability claims may result in:
decreased demand for our products;
injury to our reputation
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
decrease significantly or the vaccine could become less competitive; and
our reputation may suffer.
Any of these events could prevent us from … in:
decreased demand for our products;
injury to our reputation and significant negative media attention;
withdrawal of clinical trial participants
S-1/A
HLVX
HilleVax Inc
18 Apr 22
IPO registration (amended)
6:08am
to vaccine recipients;
sales of the vaccine may decrease significantly or the vaccine could become less competitive; and
our reputation may suffer … , liability claims may result in:
decreased demand for our products;
injury to our reputation and significant negative media attention;
withdrawal
S-1
faaxj4mvf8is5wuu
6 Apr 22
IPO registration
4:21pm
S-1
EX-10.1
et5 5qd1916k5
6 Apr 22
IPO registration
4:21pm
DRS/A
iou7g4vo4zuznvg2
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
p5m0ub26fcx5o535ms44
19 Oct 21
Draft registration statement
12:00am
DRS
EX-10.1
339qja1z1r44mlq4zndp
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next